- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Equillium Inc (EQ)
Assess today's live Equillium Inc (EQ) share price, performance and insights using our live NASDAQ: EQ stock exchange data.
Analyse the historical data and Equillium Inc share price performance charts on this page. Our technical summary section provides analysis on Equillium share price buy/sell indicators using real-time data (or discuss the Equillium (EQ) stock price today with other investors in the Equillium NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EQ share price (ISIN: US29446K1060) to enhance your trading decisions with our free investment tools and resources.
What Is the Equillium Inc Share Price Today?
The Equillium share price today is 1.520.
What Is the Stock Symbol for Equillium Inc
The stock symbol (or 'ticker') for Equillium Inc is "EQ."
What Stock Exchange Does Equillium Inc Trade On?
Equillium Inc is listed and trades on the NASDAQ stock exchange.
Is Equillium Inc a Good Stock to Buy?
Determining whether Equillium Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Equillium Inc share price performance charts on this page. Our technical summary section provides analysis on Equillium share price buy/sell indicators using real-time data (or discuss the Equillium (EQ) stock price today with other investors in the Equillium NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EQ share price (ISIN: US29446K1060) to enhance your trading decisions with our free investment tools and resources.
What Is the Equillium Inc Share Price Today?
The Equillium share price today is 1.520.
What Is the Stock Symbol for Equillium Inc
The stock symbol (or 'ticker') for Equillium Inc is "EQ."
What Stock Exchange Does Equillium Inc Trade On?
Equillium Inc is listed and trades on the NASDAQ stock exchange.
Is Equillium Inc a Good Stock to Buy?
Determining whether Equillium Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.490
1.606
52 wk Range
0.270
2.350
EQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.4901.606
52 wk Range
0.2702.350
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2.500
Upside
+64.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 144 Equillium For: 8 January
- Investing.com
- Form 13G EQUILLIUM For: 8 December
- Investing.com
- Form 144 Equillium For: 8 January
- Investing.com
- Form 13G EQUILLIUM For: 8 December
- Investing.com
- Equillium SVP Zedelmayer sells $7.7k in stock
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Equillium Company Profile
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Compare EQ to Peers and Sector
Metrics to compare | EQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEQPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −8.9x | −0.5x | |
PEG Ratio | 0.01 | −0.24 | 0.00 | |
Price/Book | 3.1x | −0.9x | 2.6x | |
Price / LTM Sales | 21.6x | 8.9x | 3.3x | |
Upside (Analyst Target) | 63.4% | 32.1% | 48.1% | |
Fair Value Upside | Unlock | −5.0% | 7.7% | Unlock |
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.500
(+64.47% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.06 / -0.22
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Equillium (EQ) Share Price Today?
The live Equillium share price today is 1.520
What Stock Exchange Does Equillium (EQ) Trade On?
Equillium is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Equillium?
The stock symbol (also called a 'ticker') for Equillium is "EQ."
What Is the Current Equillium Market Cap?
As of today, Equillium market capitalisation is 94.99M.
What Is Equillium's (EQ) Earnings Per Share (TTM)?
The Equillium EPS is currently -0.57 (Trailing Twelve Months).
When Is the Next Equillium Earnings Date?
Equillium's next earnings report will be released on 26 Mar 2026.
Is EQ a Buy or Sell From a Technical Analyst Perspective?
Based on today's Equillium moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Equillium Stock Split?
Equillium has split 1 times. (See the EQ stock split history page for full effective split date and price information.)
How Many Employees Does Equillium Have?
Equillium has 35 employees.
What is the current trading status of Equillium (EQ)?
As of 06 Feb 2026, Equillium (EQ) is trading at a price of 1.520, with a previous close of 1.480. The stock has fluctuated within a day range of 1.490 to 1.606, while its 52-week range spans from 0.270 to 2.350.
What Is Equillium (EQ) Price Target According to Analysts?
The average 12-month price target for Equillium is USD2.500, with a high estimate of USD4 and a low estimate of USD1. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +64.47% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.